Kings College London - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH142329D
- Pages: 47
- September 2018
- Total Views:1126
- Region : Europe
- GlobalData
- Equity Research Report
Details
Summary
King's College London (KCL), a subsidiary of University of London is an educational institute that offers educational services and programs. The institute offers student services such as learning and teaching; modern language center, student services, library services, student news, student opportunities, venues, students' union and IT services. It offers education services in areas of arts and humanities; dental institute, law, life sciences and medicine; natural and mathematical sciences; nursing and midwifery; psychiatry, psychology and neuroscience; and social science and public policy. The institute offers its services through undergraduate, postgraduate, internship programs, summer school, executive education and short courses. KCL is headquartered in London, the UK.
King's College London-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
King's College London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
King's College London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
King's College London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
King's College London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
King's College London, Medical Devices Deals, 2012 to YTD 2018 11
King's College London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
King's College London, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
GammaDelta Therapeutics Raises Funds through Seed Financing 14
Partnerships 15
Evolve BioSystems Enters into Partnership with King's College London 15
Evgen Pharma Enters into Agreement with King's College London 16
Plasticell Enters into Agreement with Kings College London 17
LIfT BioSciences Enters into Agreement with King's College London 18
Auris Medical Extends its Drug Discovery Agreement with King's College 19
King's College London Forms Joint Venture with Research Corporation Technologies 20
Cambridge University, Imperial College London, King's College London, Queen Mary University London, University College London and Oxford University Enter into Research and Development Agreement with Pfizer 21
Cancer Research Technology Enters Into Co-Development Agreement With ADC Therapeutics For Antibody Drug Conjugates 23
Lightlake Therapeutics To Enter Into Co-Development Agreement With King's College London 25
Licensing Agreements 26
Palleon Pharma Enters into Licensing Agreement with King's College London 26
King's College Enters into Licensing Agreement with UCB 27
King's College London Enters Into Licensing Agreement with UCB 28
Equity Offering 29
Igem Therapeutics Spin Out from King's College London 29
King's College London-Key Competitors 30
King's College London-Key Employees 31
King's College London-Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 32
Recent Developments 33
Strategy And Business Planning 33
Sep 19, 2018: Cancer Research UK launches new research hub for biotherapeutics 33
Government and Public Interest 34
Sep 18, 2018: NIHR launches largest ever study of genetic links to depression and anxiety 34
Aug 29, 2018: Cannabis extract helps reset brain function in psychosis 35
Aug 15, 2018: Researchers secure funding to investigate disease that kills millions 36
Jul 26, 2018: UK and India join forces to tackle the global health needs of women and children 37
Jun 05, 2018: Novel gene therapy technique successful in treating brain conditions 39
Feb 21, 2018: Scientists discover critical molecular biomarkers of preeclampsia 40
Feb 20, 2018: Scientists find new antimalarial drug targets 41
Nov 25, 2017: Scientists for the first-time show cancer-killing activity of human neutrophils produced in the laboratory 42
Nov 24, 2017: Scientists reveal new avenue for drug treatment in neuropathic pain 43
Nov 16, 2017: New talking therapy could help cancer survivors cope after treatment 44
Jan 31, 2017: Mind the Byte, member of consortium to receive 7 million for cancer research 45
Product News 46
Apr 25, 2017: Chemotherapy drug may increase vulnerability to depression 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
List Of Figure
List of Figures
King's College London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
King's College London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
King's College London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
King's College London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
King's College London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
King's College London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
King's College London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
King's College London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
King's College London, Medical Devices Deals, 2012 to YTD 2018 11
List Of Table
List of Tables
King's College London, Pharmaceuticals & Healthcare, Key Facts 2
King's College London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
King's College London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
King's College London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
King's College London, Deals By Therapy Area, 2012 to YTD 2018 9
King's College London, Medical Devices Deals, 2012 to YTD 2018 11
King's College London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
GammaDelta Therapeutics Raises Funds through Seed Financing 14
Evolve BioSystems Enters into Partnership with King's College London 15
Evgen Pharma Enters into Agreement with King's College London 16
Plasticell Enters into Agreement with Kings College London 17
LIfT BioSciences Enters into Agreement with King's College London 18
Auris Medical Extends its Drug Discovery Agreement with King's College 19
King's College London Forms Joint Venture with Research Corporation Technologies 20
Cambridge University, Imperial College London, King's College London, Queen Mary University London, University College London and Oxford University Enter into Research and Development Agreement with Pfizer 21
Cancer Research Technology Enters Into Co-Development Agreement With ADC Therapeutics For Antibody Drug Conjugates 23
Lightlake Therapeutics To Enter Into Co-Development Agreement With King's College London 25
Palleon Pharma Enters into Licensing Agreement with King's College London 26
King's College Enters into Licensing Agreement with UCB 27
King's College London Enters Into Licensing Agreement with UCB 28
Igem Therapeutics Spin Out from King's College London 29
King's College London, Key Competitors 30
King's College London, Key Employees 31
King's College London, Subsidiaries 32
King's College London, Joint Venture 32
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
King's College London, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
King's College London (KCL), a subsidiary of University of London is an educational institute that offers educational services and programs. The institute offers student services such as learning and teaching; modern language center, student services, library services, student news, student opportunities, venues, students' union and IT services. It offers education services in areas of arts and humanities; dental institute, law, life sciences and medicine; natural and mathematical sciences; nursing and midwifery; psychiatry, psychology and neuroscience; and social science and public policy. The institute offers its services through undergraduate, postgraduate, internship programs, summer school, executive education and short courses. KCL is headquartered in London, the UK.
King's College London-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
King's College London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
King's College London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
King's College London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
King's College London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
King's College London, Medical Devices Deals, 2012 to YTD 2018 11
King's College London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
King's College London, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
GammaDelta Therapeutics Raises Funds through Seed Financing 14
Partnerships 15
Evolve BioSystems Enters into Partnership with King's College London 15
Evgen Pharma Enters into Agreement with King's College London 16
Plasticell Enters into Agreement with Kings College London 17
LIfT BioSciences Enters into Agreement with King's College London 18
Auris Medical Extends its Drug Discovery Agreement with King's College 19
King's College London Forms Joint Venture with Research Corporation Technologies 20
Cambridge University, Imperial College London, King's College London, Queen Mary University London, University College London and Oxford University Enter into Research and Development Agreement with Pfizer 21
Cancer Research Technology Enters Into Co-Development Agreement With ADC Therapeutics For Antibody Drug Conjugates 23
Lightlake Therapeutics To Enter Into Co-Development Agreement With King's College London 25
Licensing Agreements 26
Palleon Pharma Enters into Licensing Agreement with King's College London 26
King's College Enters into Licensing Agreement with UCB 27
King's College London Enters Into Licensing Agreement with UCB 28
Equity Offering 29
Igem Therapeutics Spin Out from King's College London 29
King's College London-Key Competitors 30
King's College London-Key Employees 31
King's College London-Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 32
Recent Developments 33
Strategy And Business Planning 33
Sep 19, 2018: Cancer Research UK launches new research hub for biotherapeutics 33
Government and Public Interest 34
Sep 18, 2018: NIHR launches largest ever study of genetic links to depression and anxiety 34
Aug 29, 2018: Cannabis extract helps reset brain function in psychosis 35
Aug 15, 2018: Researchers secure funding to investigate disease that kills millions 36
Jul 26, 2018: UK and India join forces to tackle the global health needs of women and children 37
Jun 05, 2018: Novel gene therapy technique successful in treating brain conditions 39
Feb 21, 2018: Scientists discover critical molecular biomarkers of preeclampsia 40
Feb 20, 2018: Scientists find new antimalarial drug targets 41
Nov 25, 2017: Scientists for the first-time show cancer-killing activity of human neutrophils produced in the laboratory 42
Nov 24, 2017: Scientists reveal new avenue for drug treatment in neuropathic pain 43
Nov 16, 2017: New talking therapy could help cancer survivors cope after treatment 44
Jan 31, 2017: Mind the Byte, member of consortium to receive 7 million for cancer research 45
Product News 46
Apr 25, 2017: Chemotherapy drug may increase vulnerability to depression 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
List Of Figure
List of Figures
King's College London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
King's College London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
King's College London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
King's College London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
King's College London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
King's College London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
King's College London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
King's College London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
King's College London, Medical Devices Deals, 2012 to YTD 2018 11
List Of Table
List of Tables
King's College London, Pharmaceuticals & Healthcare, Key Facts 2
King's College London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
King's College London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
King's College London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
King's College London, Deals By Therapy Area, 2012 to YTD 2018 9
King's College London, Medical Devices Deals, 2012 to YTD 2018 11
King's College London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
GammaDelta Therapeutics Raises Funds through Seed Financing 14
Evolve BioSystems Enters into Partnership with King's College London 15
Evgen Pharma Enters into Agreement with King's College London 16
Plasticell Enters into Agreement with Kings College London 17
LIfT BioSciences Enters into Agreement with King's College London 18
Auris Medical Extends its Drug Discovery Agreement with King's College 19
King's College London Forms Joint Venture with Research Corporation Technologies 20
Cambridge University, Imperial College London, King's College London, Queen Mary University London, University College London and Oxford University Enter into Research and Development Agreement with Pfizer 21
Cancer Research Technology Enters Into Co-Development Agreement With ADC Therapeutics For Antibody Drug Conjugates 23
Lightlake Therapeutics To Enter Into Co-Development Agreement With King's College London 25
Palleon Pharma Enters into Licensing Agreement with King's College London 26
King's College Enters into Licensing Agreement with UCB 27
King's College London Enters Into Licensing Agreement with UCB 28
Igem Therapeutics Spin Out from King's College London 29
King's College London, Key Competitors 30
King's College London, Key Employees 31
King's College London, Subsidiaries 32
King's College London, Joint Venture 32
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
King's College London, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
January 2021
Page 94 | December 2020
Page 163 | October 2020
Page 43 | July 2020
Page 95 | July 2020